It’s no secret the cancer community has concerns regarding the future of healthcare policies in America, specifically the Affordable Care Act repeal and replace plan. Many advocates have reached out to us and passionately shared their fears. We’re listening and we’re acting!
On January 20, Fight Colorectal Cancer sent a letter to the Trump Administration with our recommendations for policy priorities. It is critically important for the new administration to remove barriers to colorectal cancer screenings, invest in research and protect patients’ best interests.
Fight CRC’s Recommendations to the Trump Administration
Below are the issues we asked President Trump to prioritize:
Remove Barriers to Colorectal Cancer Screenings
- Sign legislation into law removing the loophole in current Medicare policy requiring beneficiaries to pay co-insurance if polyps are removed during a screening colonoscopy. Fight Colorectal Cancer has worked tirelessly on this issue for the past three Congresses and most recently had more than 350 combined co-sponsors in the 114th Congress (HR 1220/S 624).
- Ensure the “replace” component of “repeal and replace” provides sufficient insurance coverage for those 50 and older and/or high-risk individuals to receive a screening colonoscopy at no charge, following USPSTF recommendations.
- Invest in community health centers and the CDC’s Colorectal Cancer Control Program (CRCCP) supporting states and tribes across the country that are providing education, patient navigation and/or free or low cost colorectal cancer screenings to underserved populations.
Invest in Research
- Follow through on momentum of the 21st Century Cures Act by ensuring funding for the Cancer Moonshot Initiative, the Precision Medicine Initiative and substantial increases to current NIH funding levels.
- Include patient feedback in discussions and decisions relating to clinical trials and treatment options.
- Revise the grant application review process to better reward bold ideas, creative risks and innovative approaches, following the Vision and Pathway for the NIH report.
Protect Patients’ Best Interests
- Ensure patients with pre-existing conditions, such as cancer, will not be denied insurance coverage or face discrimination through narrow networks and other price control measures.
- Streamline FDA processes to improve efficiency while maintaining patient safety and drug effectiveness as a top priority.
- Ensure patients receive individualized treatments that are most effective for each patient, following NCCN guidelines rather than treatment pathways or other value tools.
Now it’s your turn.
We sent our letter representing all of you, but now it’s your turn to act. With the new administration and 115th Congress in place, we need you to reach out. Email Congress and ask them to protect colorectal cancer patients as they deliberate the plan for repealing and replacing the ACA.
They need to hear your voice and know your story. Be an advocate today!Email Congress Now